Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds House Now Debating A Rule For Assault Weapons Ban Legislation For The Next Hour Followed By Votes

House Now Debating A Rule For Assault Weapons Ban Legislation For The Next Hour Followed By Votes

https://twitter.com/CraigCaplan/status/1553078050845347840

byBenzinga Newsdesk

July 29, 2022

1 minute read

House NOW debating a rule for assault weapons ban legislation for the next hour followed by votes.

— Craig Caplan (@CraigCaplan) July 29, 2022

Barrington Research Downgrades CuriosityStream to Market Perform

By Benzinga Newsdesk

August 16, 9:47 AM

Barrington Research analyst James Goss downgrades CuriosityStream (NASDAQ:CURI) from Outperform to Market Perform.

CURI

News

‘China’s Baidu Unveils Limited-Edition EV With Self-driving Tech’ – Nikkei Asia

By Benzinga Newsdesk

October 28, 11:48 AM

China's Baidu unveils limited-edition EV with self-driving tech - Nikkei Asia

BIDU

Wall Street’s Most Accurate Analysts’ Views On 3 Industrials Stocks With Over 3% Dividend Yields

By Avi Kapoor

April 26, 8:39 AM

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often…

CHRW

Regeneron Pharmaceuticals Announces Libtayo Receives Positive CHMP Opinion Recommending Approval To Treat Advanced Cervical Cancer

By Benzinga Newsdesk

October 14, 7:05 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for

REGN

House Now Debating A Rule For Assault Weapons Ban Legislation For The Next Hour Followed By Votes

Related Posts

Barrington Research Downgrades CuriosityStream to Market Perform

‘China’s Baidu Unveils Limited-Edition EV With Self-driving Tech’ – Nikkei Asia

Wall Street’s Most Accurate Analysts’ Views On 3 Industrials Stocks With Over 3% Dividend Yields

Regeneron Pharmaceuticals Announces Libtayo Receives Positive CHMP Opinion Recommending Approval To Treat Advanced Cervical Cancer